Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits <italic toggle="yes">Ex Vivo</italic> Lipopolysaccharide-Induced Inflammatory Responses
ABSTRACT Histone deacetylase inhibitors (HDACi) modulate the transcriptional activity of all cells, including innate and adaptive immune cells. Therefore, we aimed to evaluate immunological effects of treatment with the HDACi panobinostat in HIV-infected patients during a clinical phase IIa latency...
Enregistré dans:
Auteurs principaux: | Christel Rothe Brinkmann, Jesper Falkesgaard Højen, Thomas Aagaard Rasmussen, Anne Sofie Kjær, Rikke Olesen, Paul W. Denton, Lars Østergaard, Zhengyu Ouyang, Mathias Lichterfeld, Xu Yu, Ole Schmeltz Søgaard, Charles Dinarello, Martin Tolstrup |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/42a41f93e9564a62ab717ed0df2a75eb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
par: Tandon N, et autres
Publié: (2016) -
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
par: Bingyi Zhou, et autres
Publié: (2021) -
Identification of the Histone Deacetylases Gene Family in Hemp Reveals Genes Regulating Cannabinoids Synthesis
par: Liu Yang, et autres
Publié: (2021) -
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
par: Jacob King, et autres
Publié: (2021) -
Molecular cloning and subcellular localization of six HDACs and their roles in response to salt and drought stress in kenaf (Hibiscus cannabinus L.)
par: Wei,Fan, et autres
Publié: (2019)